RayBiotech
Private Company
Funding information not available
Overview
RayBiotech is a privately-held provider of protein detection and analysis solutions, operating in the life sciences tools and diagnostics sectors. The company has established a strong position in the research market with its proprietary antibody array and assay platforms, which facilitate high-throughput, multiplexed protein analysis. While primarily a tools and kits supplier, its technology supports critical workflows in drug discovery, translational research, and diagnostic development. RayBiotech's business model is based on product sales and services, generating revenue from a global customer base.
Technology Platform
Proprietary antibody-based microarray and multiplex immunoassay platforms for high-throughput protein detection and analysis, including antibody arrays and ELISA kits.
Opportunities
Risk Factors
Competitive Landscape
RayBiotech competes in the crowded life science research tools market against giants like Bio-Techne (R&D Systems), Abcam, and Thermo Fisher, as well as specialized multiplex assay companies like Luminex (now part of DiaSorin). Its competitive edge relies on its specialized antibody array expertise, broad product portfolio, and customer service.